Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

NCT02596997 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Adenovirus

Interventions

DRUG: Brincidofovir

Sponsor

Jazz Pharmaceuticals